Conversion and reversion of anti‐John Cunningham virus antibody serostatus: A prospective study

INTRODUCTION: Determination of antibodies against the John Cunningham virus (JCV) is an important tool for risk stratification in Natalizumab‐treated multiple sclerosis (MS) patients. Six‐monthly testing has been suggested for anti‐JCV antibody negative patients and patients with low antibody index...

Descripción completa

Detalles Bibliográficos
Autores principales: Auer, Michael, Hegen, Harald, Sellner, Johann, Oppermann, Katrin, Bsteh, Gabriel, Di Pauli, Franziska, Berger, Thomas, Deisenhammer, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625483/
https://www.ncbi.nlm.nih.gov/pubmed/31168964
http://dx.doi.org/10.1002/brb3.1332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625483/
https://www.ncbi.nlm.nih.gov/pubmed/31168964
http://dx.doi.org/10.1002/brb3.1332

Ejemplares similares